Guidance is available from the European Medicines Agency (EMA) on how to classify a variation for a centrally authorised veterinary medicine that is not already listed in existing guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6).
There are two types of variation established under Regulation (EU) 2019/6:
- variations not requiring assessment, which have minimal or no impact on the quality, safety or efficacy of the medicine, as listed in Commission Implementing Regulation (EU) 2021/17;
- variations requiring assessment.
When the variation marketing authorisation holders would like to make cannot be classified into either of these variation types, they can request a classification of the variation.
The Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) applies from 28 January 2022.